Tilray's HEXO Acquisition Creates Canada's Top Cannabis Company With 44% Market Share Boost

Zinger Key Points
  • The deal establishes a robust portfolio of high-growth brands and enables cost savings of about $27 million.
  • Tilray CEO Irwin D. Simon expects HEXO to boost Tilray’s "competitive positioning."

Tilray TLRY is making bold moves to secure a profitable future, and its latest acquisition of HEXO Corp. HEXO has solidified its position as Canada's top cannabis company with a 44% market share boost, expanding its market share by 467 basis points.

Despite a challenging market, the strategic combination of Tilray and HEXO is expected to drive revenue growth and create significant opportunities for increased margins and earnings, with projected annualized cost savings of over $27 million, in addition to Tilray's existing annualized cash cost savings of $122 million from the Tilray-Aphria transaction.

See Also: Tilray CFO Engages Shareholders On Reddit, Addresses Concerns And Company's Growth Strategy

Tilray CEO Irwin D. Simon expects HEXO to boost Tilray’s "competitive positioning."

"Having already established ourselves as the (...) lowest-cost production as well as industry-leading extraction capabilities (...) we expect to deliver revenue growth, margin contribution, and value creation for shareholders," he said.

“We are relentlessly focused on growing market share strategically and winning in Canada and will leverage this acquisition to expand our consumer base, serve new segments (...) We intend to capitalize on the commercial and financial benefits that are inherent in combining HEXO with Tilray. These include accelerating the optimization of our operations, sales, and marketing efforts (…)” added Blair MacNeil, President, of Tilray Canada.

The deal also establishes a robust portfolio of high-growth brands and enables cost savings of about $27 million.

  • Creates Canada’s largest cannabis company by revenue and increases Tilray’s leading cannabis share by 44% with ~13% pro forma market share
  • Accelerates the realization of operating and cost synergies above $27 Million

Solidifies Tilray’s position as the leader in cannabis operations in Canada

Related News: HEXO Q3 FY23 Revenue Declines 11% QoQ And 53% YoY, Here Are The Details

Photo by Sam Doucette on Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisM&ANewsPenny StocksMovers & ShakersAsset SalesSmall CapManagementTop StoriesMarketsGeneralBlair MacNeilHEXO Corp.Irwin SimonTilray
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.